case report, ovarian squamous cell carcinoma, rare tumors, Pembrolizumab, Immunotherapy
Ovarian cancer interval cytoreductive surgeryPeritoneal Cancer Index neoadjuvant chemotherapy histopathologic responsecomplete cytoreduction